A double-lumen intrathecal catheter for studies of modulation of spinal opiate tolerance

Journal of Neuroscience Methods

Volumn 126, Issue 2, 2003, Pages 165-173

  Hayes, Carol S ^a   Mulkmus, Shelle A ^a   Cizkova, Dasa ^a   Yaksh, Tony L ^a   Hua, Xiao Ying ^a  

^a University of California   (United States)

Author keywords

Intrathecal catheter; Opiate; Osmotic pump infusion; Spinal cord; Tolerance

Indexed keywords

OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CISTERNA MAGNA; CONTROLLED STUDY; DOUBLE LUMEN INTRATHECAL CATHETER; DOUBLE LUMEN TUBE; DRUG DELIVERY SYSTEM; DRUG INFUSION; EQUIPMENT DESIGN; INFUSION SYSTEM; MALE; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NEUROMODULATION; NOCICEPTION; NONHUMAN; OSMOTIC MINIPUMP; PATIENT COMPLIANCE; PRIORITY JOURNAL; RAT; SPINAL CORD; SUBARACHNOID SPACE;

EID: 0037566342     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(03)00078-5     Document Type: Article

References (13)

1. Baker B.F., Lot S.S., Condon T.P., Cheng-Flournoy S., Lesnik E.A., Sasmor H.M., Bennett C.F. 2′-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem. 272:1997;11994-12000.
2. Dean N.M., McKay R., Miraglia L., Geiger T., Müller M., Fabbro D., Bennett C.F. Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents. Biochem. Soc. Trans. 24:1996;623-629.
3. Dirig D.M., Salami A., Rathbun M.L., Ozaki G.T., Yaksh T.L. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J. Neurosci. Meth. 76:1997;183-191.
4. Dunbar S, Yaksh TL. Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Anesthesiology 1996;84:1177-88 [published erratum appears in Anesthesiology 1996;85(3):695].
5. Granados-Soto V., Kalcheva I., Hua X., Newton A., Yaksh T.L. Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain. 85:2000;395-404.
6. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
7. Hua X.Y., Moore A., Malkmus S., Murray S.F., Dean N., Yaksh T.L., Butler M. Inhibition of spinal protein kinase C-alpha expression by an antisense oligonucleotide attenuates morphine infusion-induced tolerance. Neuroscience. 113:2002;99-107.
8. Marsala M., Malmberg A.B., Yaksh T.L. The spinal loop dialysis catheter: characterization of use in the unanesthetized rat. J. Neurosci. Meth. 62:1995;43-53.
9. Sosnowski M., Yaksh T.L. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. Anesthesiology. 73:1990;1141-1147. [see comments].
10. Stevens C.W., Monasky M.S., Yaksh T.L. Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies. J. Pharmacol. Exp. Ther. 244:1988;63-70.
11. Williams J.T., Christie M.J., Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81:2001;299-343.
12. Yaksh T.L., Rudy T.S. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036.
13. Yaksh T.L., Stevens C.W. Simple catheter preparation for permitting bolus intrathecal administration during chronic intrathecal infusion. Pharmacol. Biochem. Behav. 25:1986;483-485.